CLINITEK ADVANTUS, MODEL 1420

Method, Enzymatic, Glucose (urinary, Non-quantitative)

BAYER HEALTHCARE, LLC

The following data is part of a premarket notification filed by Bayer Healthcare, Llc with the FDA for Clinitek Advantus, Model 1420.

Pre-market Notification Details

Device IDK063276
510k NumberK063276
Device Name:CLINITEK ADVANTUS, MODEL 1420
ClassificationMethod, Enzymatic, Glucose (urinary, Non-quantitative)
Applicant BAYER HEALTHCARE, LLC 2 EDGEWATER DR. Norwood,  MA  02062 -4658
ContactNoor Malki
CorrespondentNoor Malki
BAYER HEALTHCARE, LLC 2 EDGEWATER DR. Norwood,  MA  02062 -4658
Product CodeJIL  
Subsequent Product CodeCDM
Subsequent Product CodeCEN
Subsequent Product CodeJFY
Subsequent Product CodeJIN
Subsequent Product CodeJIO
Subsequent Product CodeJIR
Subsequent Product CodeJJB
Subsequent Product CodeJMT
Subsequent Product CodeJRE
Subsequent Product CodeKQO
Subsequent Product CodeLJX
CFR Regulation Number862.1340 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-10-30
Decision Date2006-12-28
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414593562 K063276 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.